Lentiviral Overexpression of GRK6 Alleviates L-Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease

Parkinson’s disease is caused primarily by degeneration of brain dopaminergic neurons in the substantia nigra and the consequent deficit of dopamine in the striatum. Dopamine replacement therapy with the dopamine precursor L-dopa is the mainstay of current treatment. After several years, however, th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ahmed, Mohamed R., Berthet, Amandine, Bychkov, Evgeny, Porras, Gregory, Li, Qin, Bioulac, Bernard H., Carl, Yonatan T., Bloch, Bertrand, Kook, Seunghyi, Aubert, Incarnation, Dovero, Sandra, Doudnikoff, Evelyne, Gurevich, Vsevolod V., Gurevich, Eugenia V., Bezard, Erwan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933751/
https://ncbi.nlm.nih.gov/pubmed/20410529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3000664
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak